|
Real-time Estimate
Cboe BZX
19:04:43 06/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 47.70 USD | +4.69% |
|
+14.07% | - |
| Market Cap | 2.13B 1.9B 1.73B 1.58B 2.98B 201B 3.06B 20.84B 8.33B 107B 7.99B 7.82B 336B | P/E 2026 * |
-15.7x | P/E 2027 * | -17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.88B 1.68B 1.53B 1.4B 2.64B 178B 2.71B 18.44B 7.37B 94.25B 7.07B 6.92B 297B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
89.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COAG | Delayed | |
CBOE
| COAG | Real-time |
Last Transcript: Hemab Therapeutics Holdings, Inc.
| 1 day | +4.64% | ||
| 1 week | +14.07% | ||
| Current month | +14.07% | ||
| 1 month | +66.65% | ||
| 3 months | -9.36% | ||
| 6 months | +89.04% |
| 1 week | 39.96 |  | 47.57 |
| 1 month | 27.38 | | 47.57 |
| Current year | 23 | | 55.42 |
| 1 year | 23 | | 55.42 |
| 3 years | 23 | | 55.42 |
| 5 years | 23 | | 55.42 |
| 10 years | 23 | | 55.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Benny Sorensen
CEO | Chief Executive Officer | 52 | 01/07/2021 |
| Director of Finance/CFO | 43 | 01/09/2021 | |
Ananthram Murthy
COO | Chief Operating Officer | 48 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Benny Sorensen
BRD | Director/Board Member | 52 | 01/11/2021 |
John Maraganore
CHM | Chairman | 63 | 01/01/2022 |
Linda Bain
BRD | Director/Board Member | 55 | 01/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/24/26 A | Free | Director | 36,000 | 0.0771% | ||
| 5/20/26 A | RA Capital Management LP
| Buy | Company | 996 | - | |
| 5/12/26 A | RA Capital Management LP
| Buy | Company | 6,387 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.69% | +14.07% | - | - | 2.13B | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| -0.69% | +0.37% | +9.87% | +75.44% | 57.24B | |
| -1.16% | +3.20% | +25.06% | +100.60% | 57.62B | |
| +1.51% | +1.01% | +28.06% | +36.10% | 43.65B | |
| +4.98% | +9.04% | +21.49% | +105.87% | 44.03B | |
| +5.35% | -3.14% | +201.89% | +760.26% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -2.97% | -10.12% | +88.27% | +75.62% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | +0.29% | +3.29% | +54.82% | +142.64% | 40.65B | |
| Weighted average by Cap. | -0.39% | +2.49% | +50.73% | +135.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -96.26M -85.78M -78.46M -71.45M -135M -9.1B -138M -943M -377M -4.82B -361M -354M -15.2B | -120M -107M -98.12M -89.36M -168M -11.38B -173M -1.18B -471M -6.02B -452M -442M -19.01B |
| Net Debt | -245M -219M -200M -182M -343M -23.19B -353M -2.4B -961M -12.28B -921M -901M -38.76B | -316M -282M -258M -235M -442M -29.86B -454M -3.09B -1.24B -15.81B -1.19B -1.16B -49.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | $47.28 | +3.75% | 86,272 |
| 05/11/26 | $45.57 | +1.06% | 456,594 |
| 04/11/26 | $45.09 | +4.62% | 499,702 |
| 03/11/26 | $43.10 | +4.66% | 465,845 |
| 02/11/26 | $41.18 | -0.65% | 343,875 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COAG Stock
Select your edition
All financial news and data tailored to specific country editions
